---
abstract: Abametapir 0.74% (Xeglyze) is a topical ovicidal pediculicide labeled for
  the treatment of head lice infestation in patients six months and older.1,2.
authors:
- Sunder, Meera
category: Case Study
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/35839355/
file_path: 2022/07/abametapir-074-xeglyze-for-the-treatment-of-head-lice.md
issue: '1'
keywords:
- Dermatologic Agents
- Humans
- Animals
- Pediculus
- Insecticides
- Lice Infestations
last_updated: '2025-07-30'
mesh_terms:
- Animals
- Dermatologic Agents
- Humans
- Insecticides
- Lice Infestations
- Pediculus
original_format: PubMed
pages: 91-92
patient_population: Adults
peer_reviewed: true
pmid: '35839355'
processed_date: '2025-07-30'
publication_date: '2022-07-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Abametapir 0.74% (Xeglyze) for the Treatment of Head Lice.
topics:
- Family Medicine
volume: '106'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '35839355'
  title: Abametapir 0.74% (Xeglyze) for the Treatment of Head Lice.
  abstract:
    text: Abametapir 0.74% (Xeglyze) is a topical ovicidal pediculicide labeled for
      the treatment of head lice infestation in patients six months and older.1,2.
  authors:
  - last_name: Sunder
    fore_name: Meera
    initials: M
    affiliation: Department of Family Medicine, Cambridge Health Alliance, Somerville,
      Massachusetts.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '106'
    issue: '1'
  publication_info:
    year: '2022'
    month: '07'
    full_date: '2022-07-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Animals
    major_topic: false
  - descriptor: Dermatologic Agents
    major_topic: true
  - descriptor: Humans
    major_topic: false
  - descriptor: Insecticides
    major_topic: true
  - descriptor: Lice Infestations
    major_topic: true
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Pediculus
    major_topic: true
  publication_types: *id001
related_articles:
- pmid: '35839355'
  title: Abametapir 0.74% (Xeglyze) for the Treatment of Head Lice.
  authors:
  - name: Sunder M
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2022 Jul
- pmid: '34157881'
  title: 'Abametapir for the Treatment of Head Lice: A Drug Review.'
  authors:
  - name: Woods AD
    authtype: Author
    clusterid: ''
  - name: Porter CL
    authtype: Author
    clusterid: ''
  - name: Feldman SR
    authtype: Author
    clusterid: ''
  source: Ann Pharmacother
  pubdate: 2022 Mar
- pmid: '28082644'
  title: 'Ovicidal Efficacy of Abametapir Against Eggs of Human Head and Body Lice
    (Anoplura: Pediculidae).'
  authors:
  - name: Bowles VM
    authtype: Author
    clusterid: ''
  - name: Yoon KS
    authtype: Author
    clusterid: ''
  - name: Barker SC
    authtype: Author
    clusterid: ''
  - name: Tran C
    authtype: Author
    clusterid: ''
  - name: Rhodes C
    authtype: Author
    clusterid: ''
  - name: Clark MJ
    authtype: Author
    clusterid: ''
  source: J Med Entomol
  pubdate: 2017 Jan
- pmid: '29999197'
  title: Clinical studies evaluating abametapir lotion, 0.74%, for the treatment of
    head louse infestation.
  authors:
  - name: Bowles VM
    authtype: Author
    clusterid: ''
  - name: VanLuvanee LJ
    authtype: Author
    clusterid: ''
  - name: Alsop H
    authtype: Author
    clusterid: ''
  - name: Hazan L
    authtype: Author
    clusterid: ''
  - name: Shepherd K
    authtype: Author
    clusterid: ''
  - name: Sidgiddi S
    authtype: Author
    clusterid: ''
  - name: Allenby K
    authtype: Author
    clusterid: ''
  - name: Ahveninen T
    authtype: Author
    clusterid: ''
  - name: Hanegraaf S
    authtype: Author
    clusterid: ''
  source: Pediatr Dermatol
  pubdate: 2018 Sep
- pmid: '38905531'
  title: Drugs for head lice.
  authors: []
  source: Med Lett Drugs Ther
  pubdate: 2024 Jun 10
---

# Abametapir 0.74% (Xeglyze) for the Treatment of Head Lice.

**Authors:** Sunder, Meera

**Published in:** American family physician | Vol. 106, No. 1 | 2022-07-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/35839355/)

## Abstract

Abametapir 0.74% (Xeglyze) is a topical ovicidal pediculicide labeled for the treatment of head lice infestation in patients six months and older.1,2.

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Animals, Dermatologic Agents, Humans, Insecticides, Lice Infestations, Pediculus

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/35839355/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
